National Comprehensive Cancer Network

About NCCN

Updated Patient Resource for Pancreatic Cancer Now Available on

By Lacey Marlow, Associate Medical Writer, NCCN

The NCCN Guidelines for Patients®: Pancreatic Cancer, Version 1.2014, is now available on This NCCN Guidelines for Patients® is a high-quality resource for patients and caregivers in the process of planning or receiving treatment. It includes the most recent test and treatment recommendations for each stage of Pancreatic Cancer.

The National Comprehensive Cancer Network® (NCCN®) aims to provide people with cancer and the general public with state-of-the-art cancer treatment information in easy-to-understand language. The NCCN Guidelines for Patients, translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), are meant to help patients with cancer talk to their doctors about the best treatment options for the type of cancer they have.

The NCCN Guidelines for Patients®: Pancreatic Cancer is dedicated to the memory of Debra (Debbie) Hampton, a beloved member of the NCCN team who lost her three-year battle with pancreatic cancer in February 2013. Debbie was a passionate and dedicated advocate for supporting innovative cancer treatment research, serving as Manager, NCCN Oncology Research Program (ORP) for more than 12 years. In honor of Debbie, may this book provide treatment guidance, support, and understanding to anyone—patient, caregiver, or loved one—navigating the path of pancreatic cancer diagnosis and treatment.

The NCCN Guidelines for Patients®: Pancreatic Cancer was developed according to plain language principles to improve health literacy. The design and format feature patient-friendly elements such as medical illustrations alongside descriptions of body parts, tests, and treatments. It also includes an expansive glossary with definitions of medical terms and acronyms.

This update includes important changes to the organization and structure of the Treatment guide. Recommendations in the Treatment guide are now divided into four sections, based on the pancreatic cancer stage: resectable, borderline resectable, locally advanced unresectable, and metastatic. And, two new first-line treatment options have been added for locally advanced unresectable and metastatic pancreatic cancer.

NCCN currently offers NCCN Guidelines for Patients for the following: Breast, Colon, Esophageal, Non-Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers, Chronic Myelogenous Leukemia, Lung Cancer Screening, Malignant Pleural Mesothelioma, Melanoma, Multiple Myeloma, and Caring for Adolescents and Young Adults (AYA).

The library of NCCN Guidelines for Patients are available free-of-charge at

Funding for the NCCN Guidelines for Patients is made possible through the NCCN Foundation®